Stealth BioTherapeutics Corp. Sponsored ADR Operating Income 2019-2022 | MITO
Stealth BioTherapeutics Corp. Sponsored ADR operating income from 2019 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Stealth BioTherapeutics Corp. Sponsored ADR Annual Operating Income (Millions of US $) |
|
|---|---|
| 2021 | $-46 |
| 2020 | $-49 |
| 2019 | $-46 |
| 2018 | $-75 |
| 2017 | $-80 |
| Stealth BioTherapeutics Corp. Sponsored ADR Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2022-03-31 | $-13 |
| 2021-12-31 | $-13 |
| 2021-09-30 | $-11 |
| 2021-06-30 | $-11 |
| 2021-03-31 | $-11 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $-11 |
| 2020-06-30 | $-12 |
| 2020-03-31 | $-15 |
| 2019-12-31 | $-17 |
| 2019-09-30 | $-16 |
| 2019-06-30 | $-15 |
| 2019-03-31 | $-18 |
| 2018-12-31 | $-21 |
| 2018-09-30 | $-21 |
| 2018-06-30 | $-16 |
| 2018-03-31 | $-17 |
